Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:47 PM
Study NCT ID:
NCT04911894
Status:
COMPLETED
Last Update Posted:
2023-03-01
First Post:
2021-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Dose Escalation of IBI321 in Patients With Advanced Solid Tumors
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-17
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-25
First Submit QC Date:
None
Study First Post Date:
2021-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-27
Last Update Post Date:
2023-03-01
Last Update Post Date Type:
ACTUAL